AriellaKelmanMD

Crystal Related, Lupus & Related, Rheumatoid Arthritis & Related

Stanford University School of Medicine Division of Immunology and Rheumatology

Dr. Kelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2003 - 2005
Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 1999 - 2001
Kaiser Permanente Southern California (Los Angeles)Internship, Internal Medicine, 1998 - 1999
Tel Aviv University SacklerClass of 1998

PubMed

132 citations
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
Gerd R Burmester, William F. C. Rigby, Ronald F van Vollenhoven, Jonathan Kay, Andrea Rubbert-Roth
Annals of the Rheumatic Diseases. 2016-06-01
67 citations
A review of anabolic therapies for osteoporosis
Nancy E Lane, Ariella Kelman
Arthritis Research & Therapy. 2003-08-05
53 citations
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis
Mark C. Genovese, Joel M. Kremer, Ronald F van Vollenhoven, Rieke Alten, Juan Jose Scali
Arthritis & Rheumatology. 2017-09-01

Considerations for Applying Bioethics Norms to a Biopharmaceutical Industry SettingMarch 25th, 2021
Biora Therapeutics : Phase 1 Clinical Trial of BT-600 Presentation July 2024July 18th, 2024